Hepatitis

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

NIH Updates Hepatitis B Strategic Plan to Focus on Developing Cure

August 08, 2022

Article

Revised plan incorporates lessons from the COVID-19 pandemic and recent advances in technology, aligning with the Department of Health and Human Services’ roadmap.

Bepirovirsen Reduces Levels of Hepatitis B Surface Antigen, Hepatitis B Virus DNA

August 08, 2022

Article

The B-Clear study investigated the efficacy and safety of 12- or 24-weeks treatment with bepirovirsen in individuals with chronic hepatitis B.

Biktarvy Demonstrates High Efficacy for Broad Range of Patients Initiating Treatment for HIV

August 03, 2022

Article

Participants who initiated treatment with Biktarvy demonstrated superior hepatitis B virus (HBV) DNA suppression and HBV e-antigen seroconversion.

Heavy Alcoholism, ALDH2 rs671 Polymorphism Associated with Higher Risk of Hepatocellular Carcinoma, Mortality

August 01, 2022

Article

Heavy alcohol intake and ALDH2 rs671 polymorphism are among many risk factors associated with increased risk of hepatocellular carcinoma and mortality in patients with hepatitis B virus-related cirrhosis.

Rates of Severe Acute Hepatitis of Unknown Causes in Children Are Increasing in US, UK

July 22, 2022

Article

A possibly life-threatening and transmissible liver disease has been affecting children in the US and the UK since 2021.

Roche Launches Dual Antibody, Antigen Hepatitis C Virus Diagnostic Test

July 20, 2022

Article

Elecsys HCV Duo allows independent and simultaneous determination of early-stage infection and those who are recovering or showing signs of a chronic problem.

Clinical Overview: Glucarpidase (Voraxaze) for Methotrexate Toxicity

July 12, 2022

Article

Methotrexate is an immunosuppressive agent used to treat cancer, dermatology-, and rheumatology-related issues.

Pediatric Hepatitis Levels Remain Consistent With Pre-Pandemic Levels

July 12, 2022

Article

Hepatitis-associated emergency department visits and hospitalizations, liver transplantations, and adenovirus stool testing results in pediatric patients were not found to increase during the COVID-19 pandemic.

Hepcludex Shows Efficacy Treating Chronic Hepatitis Delta Virus

July 01, 2022

Article

Findings from a study highlight the efficacy and safety of bulevirtide for the treatment of chronic hepatitis delta virus.

Coexisting Hepatitis B Surface Antigens, Antibodies Lead to More Severe Liver Disease

June 21, 2022

Article

The coexistence of hepatitis B virus (HBV) surface antigens and antibodies against are an atypical serological profile for patients with chronic HBV infections.